Drawing for QP BREAST

USPTO serial 97676171

QP BREAST

Reviewed by CopyMark Law Group

Reg. 7491243Status 700Registered
Filing date
Status date
Registration date
Sep 3, 2024
Examiner
PERKINS, ELLEN J
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with QP BREAST?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jeffrey H. Handelsman

Jeffrey H. Handelsman GREENBLUM & BERNSTEIN, P.L.C.1950 ROLAND CLARKE PLACERESTON, VA 20191-1411UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Downloadable cloud-based medical software platform provided to hospitals, healthcare facilities, medical laboratories and other companies in the healthcare industry for processing digital medical images for biomarker imaging diagnosis and treatmentACTIVE—
042Scientific and technological services as well as research and design services related thereto, namely, scientific research and platform as a service (PAAS) featuring computer software platforms using artificial intelligence for processing digital medical images; Software as a service (SaaS) services featuring software for post processing of magnetic resonance imaging, computer tomography or other imaging modalities for medical diagnosis; provision of non-downloadable software over a global computer network and temporary use of non-downloadable online software for data transmission; research services for medical purposes, namely, medical research; engineering design services; provision of scientific expertise, namely, providing information about scientific research; research and development services in the field of medicine for clinical pathology diagnosis; electronic data storage of medical records; design and development of computer software for image processing; technological and scientific services, namely, scientific research in the field of medical imaging; scientific research for medical purposes in the field of prostate cancer, lung cancer, breast cancer, neurodegenerative diseases and chronic liver disease; provision of scientific information regarding medical disorders and their treatment; scientific research and analysis in the field of medical imaging; computer-aided industrial analysis services, namely, computer systems analysis; engineering drawing services; medical and pharmaceutical research services; medical and scientific research, namely, conducting clinical trials for othersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 3, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Sep 3, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 18, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 18, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 29, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 13, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 13, 2024XAECEXAMINER'S AMENDMENT ENTERED—
May 13, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 13, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
May 13, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 24, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 24, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 24, 2024ALIEASSIGNED TO LIE—
Dec 5, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 5, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 5, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 5, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 28, 2023DOCKASSIGNED TO EXAMINER—
Dec 5, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 17, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance